p53 mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection

Oncology

Volumn 71, Issue 3-4, 2007, Pages 237-245

  Kobayashi, Maki ^a   Kawachi, Hiroshi ^a,c   Takizawa, Toichiro ^a   Uchida, Keisuke ^a   Sekine, Masaki ^a   Kumagai, Jiro ^a   Momma, Kumiko ^b   Nemoto, Tetsuo ^b   Akashi, Takumi ^a   Funata, Nobuaki ^b   Eishi, Yoshinobu ^a   Koike, Morio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Direct sequence; Esophageal cancer; Esophageal dysplasia; Immunohistochemistry; Microdissection; p53 mutation; Squamous cell carcinoma

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA EXTRACTION; DYSPLASIA; ESOPHAGUS CARCINOMA; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

CARCINOMA IN SITU; ESOPHAGEAL NEOPLASMS; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548087020     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106448     Document Type: Article

References (28)

1. Holscher AH, Bollschweiller E, Bumm R, Bartels H, Holfer H, Siewert JR: Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995;118:845-855.
2. Lerut TE, De Leyn P, Coosemans W, Van Raemdonck D, Cuypers Ph, Van Cleinenbreughel B: Advanced esophageal carcinoma. World J Surg 1994;18:379-387.
3. Ide H, Nakumura T, Hayashi K, Endo T, Kobayashi A, Eguchi R, Hanyu F: Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 1994;18:321-330.
4. Nigro JJ, DeMeester SR, Hagen JA, DeMeester TR, Peters JH, Kiyabu M, Campos GM, Oberg S, Gastal O, Crookes PF, Bremner CG: Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999;117:960-968.
5. Soetikno R, Kaltenbach T, Yeh R, Gotoda T: Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 2005;23:4490-4498.
6. Hamilton SR, Aaltonen LA (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon, IARC Press, 2000.
7. Kitamura K, Kuwano H, Yasuda M, Sonoda K, Sumiyoshi K, Tsutsui S, Kitamura M, Sugimachi K: What is the earliest malignant lesion in the esophagus? Cancer 1996;77(suppl 8):1614-1619.
8. Wahl GM, Linke SP, Paulson TG, Huang LC: Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Serv 1997;29:183-219.
9. Robles AL, Harris CC: p53-mediated apoptosis and genomic instability diseases. Acta Oncol 2001;40:696-701.
10. Mitoyama N, Naka K: DNA damage tumor suppressor genes and genomic instability. Curr Opin Genet Dev 2004;14:11-16.
11. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Binger SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weslon A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-708.
12. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, van Tuinen P, Ledbetter DH, Baker DF, Nakamura Y, White R, Vogelstein B: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-221.
13. Isono K, Sato H, Nakamura K: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-420.
14. Volant A, Nousbaum JB, Giroux MA, Roue-Quintin I, Metges JP, Ferec C, Metges JP, Gouerou H, Robaszkiewicz M: p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions. J Clin Pathol 1995;48:531-534.
15. Kawamura T, Goseki N, Koike M, Takizawa T, Endo M: Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings. Cancer 1996;77:843-849.
16. Tian D, Feng Z, Hanley NM, Woodrow Setzer R, Judy L, Mumford JL, Demarini DM: Multifocal accumulation of p53 protein in esophageal carcinoma: evidence for field cancerization. Int J Cancer 1998;78:568-575.
17. Wang LD, Hong JY, Qiu SL, Gao H, Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions. Cancer Res 1993;53:1783-1787.
18. Wang LD, Zhou Q, Hong JY, Qiu SL, Yang CS: p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high risk populations in Henan, China. Cancer 1996;77:1244-1249.
19. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP: p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992;52:6092-6097.
20. International Agency for Research on Cancer: IARC TP53 mutation database (database on the Internet). R10, released in July 2005. http://www-p53.iarc.fr/.
21. Hussain SP, Harris CC: Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogenesis. Mutat Res 2000;462:311-322.
22. Juven-Gershon T, Oren M: Mdm2: the ups and downs. Mol Med 1999;5:71-83.
23. Scheffner M, Nuber U, Huibregtse JM: Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995;373:81-83.
24. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991;253:49-53.
25. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
26. Hainaut P, Vahakangas K: p53 as a sensor of carcinogenic exposures: mechanisms of p53 protein induction and lessons from p53 gene mutations. Pathol Biol (Paris) 1997;45:833-844.
27. Cho Y, Gorina S, Jeffrey PD, Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994;265:346-355.
28. Zambetti GP, Levine AJ: A comparison of the biological activities of wild-type and mutant p53. FASEB J 1993;7:8558-8565.